CBDX.US Curative Biosciences Inc

Healthcare Pharmaceuticals USA Stocks
0.0001 USD
Close of Mar 14, 2026
0.0001 0.0002
Market cap
USD 3.16K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Mar 2018.

Is CBDX.US undervalued?

Graham number

The Graham number of Curative Biosciences Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Curative Biosciences Inc fundamental analysis

No fundamental analysis for Curative Biosciences Inc yet.

Curative Biosciences Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Curative Biosciences Inc

Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. It intends to manufacture and market natural health products and operate in the medical cannabis industry. The company was formerly known as Amaize Beverage Corporation and changed its name to Curative Biosciences, Inc. in August 2017. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida.

Full company profile